CDI-dependent dendritic cell instruction

Nature Immunology

Volumn 3, Issue 12, 2002, Pages 1163-1168

  Vincent, Michael S ^a   Lesli, David S ^a   Gumperz, Jenny E ^a   Xiong, Xiaowei ^a   Grant, Ethan P ^b   Brenner, Michael B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD1 ANTIGEN; CD40 LIGAND; FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 12; ISOPROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN P70; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CELL INTERACTION; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; T LYMPHOCYTE; CELL COMMUNICATION; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CYTOLOGY; IMMUNOLOGY;

ANTIGENS, CD1; CELL COMMUNICATION; CELL DIFFERENTIATION; DENDRITIC CELLS; HUMANS; IMMUNITY, CELLULAR; T-LYMPHOCYTES;

EID: 0036882074     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni851     Document Type: Article

References (45)

1. Lanzavecchia, A. & Sallusto, F. Regulation of T cell immunity by dendritic cells. Cell 106, 263-266 (2001).
2. Hilkens, C. M., Kalinski, P., de Boer, M. & Kapsenberg, M. L. Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype. Blood 90, 1920-1926 (1997).
3. Schulz, O. et al. CD40 triggering of heterodimeric IL-12p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity 13, 453-462 (2000).
4. Hawiger D. et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194, 769-779 (2001).
5. Kalinski, P., Schuitemaker, J. H., Hilkens, C. M., Wierenga, E.A. & Kapsenberg, M. L. Final maturation of dendritic cells is associated with impaired responsiveness to IFN-γ and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells. J. Immunol. 162, 3231-3236 (1999).
6. H2 and nonpolarized T cells. Nature Immunol. 1, 311-316 (2000).
7. Porcelli, S. A. & Modlin, R. L. The CDI system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu. Rev. Immunol. 17, 297-329 (1999).
8. α24 T cells: lymphocytes of innate immunity. Semin. Immunol. 12, 537-542 (2000).
9. + T cells. Nature 372, 691-694 (1994).
10. Sieling, P.A. et al. CDI-restricted T cell recognition of microbial lipoglycan antigens. Science 269, 227-230 (1995).
11. Moody, D. B. et al. Structural requirements for glycolipid antigen recognition by CDIb-restricted T cells. Science 278, 283-286 (1997).
12. Shamshiev A. et al. Self glycolipids as T-cell autoantigens. Eur J. Immunol. 29, 1667-1675 (1999).
13. Shamshiev A. et al. Presentation of the same glycolipid by different CDI molecules. J. Exp. Med. 195, 1013-1021 (2002).
14. - T cells. J. Exp. Med. 186, 109-120 (1997).
15. Gumperz, J. E., Miyake, S., Yamamum, T. & Brenner, M. B. Functionally distinct subsets of CDId-restricted natural killer T cells revealed by CDId tetramer staining. J. Exp. Med. 195, 625-636 (2002).
16. Pierre, P. et al. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388, 787-792 (1997).
17. Sallusto, F. & Lanzavecchia, A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med 179, 1109-1118 (1994).
18. Caux, C. et al. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180, 1263-1272 (1994).
19. Anderson, D. M. et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390, 175-179 (1997).
20. Rescigno, M. et al. Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-1β, and the production of interferon γ in the absence of IL-12 during DC-T cell cognate interaction: a new role for Fas ligand in inflammatory responses. J. Exp. Med. 192, 1661-1668 (2000).
21. α24 natural killer T cells expressing CD40L. Immunology 102, 137-145 (2001).
22. Vieira, P. L., de Jong, E. C., Wierenga, E. A., Kapsenberg, M. L. & Kalinski, P. Development of ThI-inducing capacity in myeloid dendritic cells requires environmental instruction. J. Immunol. 164, 4507-4512 (2000).
23. Corinti, S., Albanesi, C., la Sala, A., Pastore, S. & Girolomoni, G. Regulatory activity of autocrine IL-10 on dendritic cell functions. J. Immunol. 166, 4312-4318 (2001).
24. Kitamura, H. et al. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med. 189, 1121-1128 (1999).
25. Exley, M.A. et al. Cutting edge: Compartmentalization of ThI-like noninvariant CDId-reactive T cells in hepatitis C virus-infected liver. J. Immunol. 168, 1519-1523 (2002).
26. Sieling, P.A. et al. Human double-negative T cells in systemic lupus erythematosus provide help for IgG and are restricted by CDIc. J. Immunol. 165, 5338-5344 (2000).
27. + T cells in the development of T helper type I responses. J. Exp. Med. 195, 473-483 (2002).
28. Gerosa, F. et al. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195, 327-333 (2002).
29. Piccioli, D., Sbrana, S., Melandri, E. & Valiante, N. M. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med 195, 335-341 (2002).
30. Ferlazzo, G. et al. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195, 343-351 (2002).
31. Exley, M.A. et al. A major fraction of human bone marrow lymphocytes are Th2-like CDId-reactive T cells that can suppress mixed lymphocyte responses. J. Immunol. 167, 5531-5534 (2001).
32. Reinhardt, R. L., Khoruts, A., Merica, R., Zell, T & Jenkins, M. K. Visualizing the generation of memory CD4T cells in the whole body. Nature 410, 101-105 (2001).
33. Masopust, D., Vezys, V., Marzo, A. L. & Lefrancois, L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291, 2413-2417 (2001).
34. + NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J. Immunol. 166, 6477-6482 (2001).
35. + NKT cell subsets with distinct cytokine-producing capacity. Blood 100, 11-16 (2002).
36. Sallusto, F. et al. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur J. Immunol. 29, 1617-1625 (1999).
37. Huang, Q. et al. The plasticity of dendritic cell responses to pathogens and their components. Science 294, 870-875 (2001).
38. Kumar, H., Belperron, A., Barthold, S.W. & Bockenstedt, L. K. Cutting edge: CDId deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi. J. Immunol. 165, 4797-4801 (2000).
39. α14 NKT cells in lungs and their roles in ThI response and host defense in cryptococcal infection. J. Immunol. 167, 6525-6532 (2001).
40. Nieuwenhuis, E. E. et al. CDId-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nature Med. 8, 588-593 (2002).
41. - cytolytic T lymphocytes. Nature 341, 447-450 (1989).
42. Grant, E. P. et al. Molecular recognition of lipid antigens by T cell receptors. J. Exp. Med. 189, 195-205 (1999).
43. Behar, S. M., Porcelli, S.A., Beckman, E. M. & Brenner, M. B. A pathway of costimulation that prevents anergy in CD28 T cells: B7-independent costimulation of CDI-restricted T cells. J. Exp. Med. 182, 2007-2018 (1995).
44. Carlsson, S. R., Roth, J., Piller, F. & Fukuda, M. Isolation and characterization of human lysosomal membrane glycoproteins, h-lamp-1 and h-lamp-2. Major sialoglycoproteins carrying polylactosaminoglycan. J. Biol. Chem. 263, 18911-18919 (1988).
45. Sugita, M. et al. Separate pathways for antigen presentation by CDI molecules. Immunity 11, 743-752 (1999).